Doctor Ioanna DIMA
Hippokration General Hospital, Athens (Greece)
Coronary artery disease and familial hypercholesterolaemia patients' eligibility for pcsk-9 inhibitors: who is to benefit from lower ldl thresholds?
Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session: Risk Factors and Prevention ePosters
Lipoprotein (a) and cardiovascular risk in familial combined hyperlipidaemia: does it exist?
Event: ESC Congress 2021 - The Digital Experience
Topic: Lipids
Session: Risk Factors and Prevention ePosters
Treatment with a fixed dose combination for cardiovascular disease-more than a health benefit?
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology
Session: Risk Factors and Prevention ePosters
A predictive model of pcsk-9 inhibitors eligibility in coronary and dyslipidemic patients
Event: ESC Congress 2020
Topic: Lipids
Session: Risk Factors and Prevention ePosters
ESC 365 is supported by
